These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35812726)

  • 1. Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment.
    Chen H; Chen G
    Front Genet; 2022; 13():883583. PubMed ID: 35812726
    [No Abstract]   [Full Text] [Related]  

  • 2. Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment.
    Wang L; He T; Liu J; Tai J; Wang B; Chen Z; Quan Z
    Exp Hematol Oncol; 2021 May; 10(1):31. PubMed ID: 33971970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients.
    Ma L; Chen H; Yang W; Ji Z
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 6. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Zhang Z; Tan J; Yu Z; Liu C; Wang J; Wu D; Bai X
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):667-679. PubMed ID: 37313807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
    Hu J; Yu A; Othmane B; Qiu D; Li H; Li C; Liu P; Ren W; Chen M; Gong G; Guo X; Zhang H; Chen J; Zu X
    Theranostics; 2021; 11(7):3089-3108. PubMed ID: 33537076
    [No Abstract]   [Full Text] [Related]  

  • 9. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer.
    Li J; Tang Y; Long F; Tian L; Tang A; Ding L; Chen J; Liu M
    Comput Struct Biotechnol J; 2024 Dec; 23():2251-2266. PubMed ID: 38827236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment.
    Ma C; Yang C; Peng A; Sun T; Ji X; Mi J; Wei L; Shen S; Feng Q
    Mol Cancer; 2023 Oct; 22(1):170. PubMed ID: 37833788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and Immunological Implications of MME
    Wang B; Pan Y; Xie Y; Wang C; Yang Y; Sun H; Yan Z; Cui Y; Li L; Zhou Y; Liu W; Pan Z
    Biol Proced Online; 2024 Sep; 26(1):29. PubMed ID: 39342097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression.
    Shen R; Li P; Zhang B; Feng L; Cheng S
    J Transl Med; 2022 Oct; 20(1):462. PubMed ID: 36209225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
    Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
    Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.
    Nishikawa H; Koyama S
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Transcriptome Analysis Reveals Changes of Tumor Immune Microenvironment in Oral Squamous Cell Carcinoma After Chemotherapy.
    Song H; Lou C; Ma J; Gong Q; Tian Z; You Y; Ren G; Guo W; Wang Y; He K; Xiao M
    Front Cell Dev Biol; 2022; 10():914120. PubMed ID: 35784460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis.
    Guo H; Zhang L; Su H; Yang J; Lei J; Li X; Zhang S; Zhang X
    Heliyon; 2024 Sep; 10(18):e38014. PubMed ID: 39347397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census.
    Wei C; Ma Y; Wang M; Wang S; Yu W; Dong S; Deng W; Bie L; Zhang C; Shen W; Xia Q; Luo S; Li N
    NPJ Precis Oncol; 2024 Aug; 8(1):176. PubMed ID: 39117688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.